Sex and racial/ethnic differences in premature mortality due to HIV: Florida, 2000–2009

Public Health Reports

Volumn 130, Issue 5, 2015, Pages 505-513

  Trepka, Mary Jo ^a   Niyonsenga, Theophile ^b   Fennie, Kristopher P ^a   McKelvey, Karma ^a   Lieb, Spencer ^c   Maddox, Lorene M ^d  

^a FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^c Florida Consortium for HIV AIDS Research The AIDS Institute   (United States)

^d FLORIDA DEPARTMENT OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; BLACK PERSON; CAUCASIAN; ETHNIC DIFFERENCE; FEMALE; HISPANIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MULTILEVEL ANALYSIS; POVERTY; PREMATURE MORTALITY; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; UNITED STATES; AFRICAN AMERICAN; CAUSE OF DEATH; EARLY DIAGNOSIS; ECONOMICS; EPIDEMIOLOGY; ETHNOLOGY; HEALTH CARE DISPARITY; HEALTH SURVEY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; MIDDLE AGED; MINORITY HEALTH; MORTALITY; SEX RATIO; STATISTICS AND NUMERICAL DATA; UTILIZATION; YOUNG ADULT;

ADULT; AFRICAN AMERICANS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CAUSE OF DEATH; EARLY DIAGNOSIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FLORIDA; HEALTHCARE DISPARITIES; HISPANIC AMERICANS; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MINORITY HEALTH; MORTALITY, PREMATURE; MULTILEVEL ANALYSIS; POPULATION SURVEILLANCE; POVERTY AREAS; SEX DISTRIBUTION; YOUNG ADULT;

EID: 84940373901     PISSN: 00333549     EISSN: 14682877     Source Type: Journal    
DOI: 10.1177/003335491513000513     Document Type: Article

References (49)

1. Prejean J, Song R, Hernandez A, Ziebell R, Green T, Walker F, et al. Estimated HIV incidence in the United States, 2006-2009. PLoS One 2011; 6: e17502.
2. National Center for Health Statistics (US). Health, United States, 2013: with special feature on prescription drugs. Hyattsville (MD): NCHS; 2014. Also available from: URL: http://www. cdc. gov/nchs/data/hus/hus13. pdf [cited 2013 Nov 18].
3. Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet 2008; 372: 293-9.
4. Samji H, Cescon A, Hogg RS, Modur SP, Althoff KN, Buchacz K, et al. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS One 2013; 8; e81355.
5. Krentz HB, Kliewer G, Gill MJ. Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003. HIV Med 2005; 6: 99-106.
6. Bonnet F, Burty C, Lewden C, Costagliola D, May T, Bouteloup V, et al. Changes in cancer mortality among HIV-infected patients: the Mortalité 2005 Survey. Clin Infect Dis 2009; 48: 633-9.
7. Cohen MH, French AL, Benning L, Kovacs A, Anastos K, Young M, et al. Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapy. Am J Med 2002; 113: 91-8.
8. Crum NF, Riffenburgh RH, Wegner S, Agan BK, Tasker SA, Spooner KM, et al. Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. J Acquir Immune Defic Syndr 2006; 41: 194-200.
9. Pacheco AG, Tuboi SH, May SB, Moreira LF, Ramadas L, Nunes EP, et al. Temporal changes in causes of death among HIV-infected patients in the HAART era in Rio de Janeiro, Brazil. J Acquir Immune Defic Syndr 2009; 51: 624-30.
10. Wada N, Jacobson LP, Cohen M, French A, Phair J, Muñoz A. Cause-specific life expectancies after 35 years of age for human immunodeficiency syndrome-infected and human immunodeficiency syndrome-negative individuals followed simultaneously in long-term cohort studies, 1984-2008. Am J Epidemiol 2013; 177: 116-25.
11. Hall HI, Frazier EL, Rhodes P, Holtgrave DR, Furlow-Parmley C, Tang T, et al. Differences in human immunodeficiency virus care and treatment among subpopulations in the United States. JAMA Intern Med 2013; 173: 1337-44.
12. Gardner JW, Sanborn JS. Years of potential life lost (YPLL)-what does it measure? Epidemiology 1990; 1: 322-9.
13. Schneider E, Whitmore S, Glynn MK, Dominguez K, Mitsch A, McKenna MT. Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged, 18 months and for HIV infection and AIDS among children aged 18 months to, 13 years-United States, 2008. MMWR Recomm Rep 2008; 57(10): 1-8.
14. Fleming PL, Ward JW, Janssen RS, De Cock KM, Valdiserri RO, Gayle HD, et al. Guidelines for national human immunodeficiency virus case surveillance, including monitoring for human immunodeficiency virus infection and acquired immunodeficiency syndrome. MMWR Recomm Rep 1999; 48(RR13): 1-28.
15. Centers for Disease Control and Prevention, Health Resources and Services Administration (US), National Institutes of Health, American Academy of HIV Medicine, Association of Nurses in AIDS Care, International Association of Providers of AIDS Care, the National Minority AIDS Council and the Urban Coalition for HIV/AIDS Prevention Services. Recommendations for HIV prevention with adults and adolescents with HIV in the United States, 2014. Atlanta: CDC; 2014. Also available from: URL: http://stacks. cdc. gov/view/cdc/26062 [cited 2015 Feb 10].
16. World Health Organization. International classification of diseases, tenth revision. 1994 [cited 2014 Feb 3]. Available from: URL: http://www. who. int/classifications/icd/en.
17. Kochanek KD, Arias E, Anderson RN. How did cause of death contribute to racial differences in life expectancy in the United States in 2010. NCHS Data Brief 2013; 125: 1-8.
18. Census Bureau (US). American FactFinder: community facts [cited 2012 Nov 26]. Available from: URL: http://factfinder2. census. gov/faces/nav/jsf/pages/index. xhtml.
19. Census Bureau (US). ZIP Code™ Tabulation Areas (ZCTAs™) [cited 2013 May 7]. Available from: URL: http://www. census. gov/geo/reference/zctas. html.
20. Trepka MJ, Niyonsenga T, Maddox L, Lieb S, Lutfi K, Pavlova-McCalla E. Community poverty and trends in racial/ethnic survival disparities among people diagnosed with AIDS in Florida, 1993-2004. Am J Public Health 2013; 103: 717-26.
21. Arias E. United States life tables, 2009. Natl Vital Stat Rep 2014 Jan 16; 62: 1-63.
22. Arias E. United States life tables, 2008. Natl Vital Stat Rep 2012 Sep 24; 61: 1-64.
23. Arias E. United States life tables, 2007. Natl Vital Stat Rep 2011 Sep 28; 59: 1-61.
24. Arias E. United States life tables, 2006. Natl Vital Stat Rep 2010 Jun 28; 58: 1-40.
25. Arias E, Rostron BL, Tejada-Vera B. United States life tables, 2005. Natl Vital Stat Rep 2010 Mar 3; 58: 1-132.
26. Bergen H, Hawton K, Waters K, Ness J, Cooper J, Steeg S, et al. Premature death after self-harm: a multicentre cohort study. Lancet 2012; 380: 1568-74.
27. Degenhardt L, Larney S, Randall D, Burns L, Hall W. Causes of death in a cohort treated for opioid dependence between 1985 and 2005. Addiction 2014; 109: 90-9.
28. Harrison KM, Song R, Zhang X. Life expectancy after HIV diagnosis based on national HIV surveillance data from 25 states, United States. J Acquir Immune Defic Syndr 2010; 53: 124-30.
29. Pham TM, Fujino Y, Ide R, Tokui N, Kubo T, Mizoue T, et al. Years of life lost due to cancer in a cohort study in Japan. Eur J Public Health 2009; 19: 189-92.
30. Seifarth JE, McGowan CL, Milne KJ. Sex and life expectancy. Gend Med 2012; 9: 390-401.
31. Klein RJ, Schoenborn CA. Age adjustment using the 2000 projected U. S. population. Healthy People 2010 Stat Notes 2001; (20): 1-10.
32. Fay MP, Feuer EJ. Confidence intervals for directly standardized rates: a method based on the gamma distribution. Stat Med 1997; 16: 791-801.
33. McCullagh P, Nelder JA. Generalized linear models. 2nd ed. London: Chapman & Hall/CRC; 1989.
34. Washington State Department of Health. Guidelines for using confidence intervals for public health assessment. 2012 [cited 2014 Apr 17]. Available from: URL: http://www. doh. wa. gov/portals/1/documents/5500/ConfIntGuide. pdf.
35. Kiernan K, Tao J, Gibbs P. Tips and strategies for mixed modeling with SAS/STAT® procedures. Paper 332-2012. Cary (NC): SAS Institute, Inc.; 2012.
36. SAS Institute, Inc. SAS®: Version 9. 3. Cary (NC): SAS Institute, Inc.; 2010.
37. Bastard M, Soulinphumy K, Phimmasone P, Saadani AH, Ciaffi L, Communier A, et al. Women experience a better long-term immune recovery and a better survival on HAART in Lao People's Democratic Republic. BMC Infect Dis 2013; 13: 27.
38. Jarrin I, Geskus R, Bhaskaran K, Prins M, Perez-Hoyos S, Muga R, et al. Gender differences in HIV progression to AIDS and death in industrialized countries: slower disease progression following HIV seroconversion in women. Am J Epidemiol 2008; 168: 532-40.
39. Nicastri E, Leone S, Angeletti C, Palmisano L, Sarmati L, Chiesi A, et al. Sex issues in HIV-1-infected persons during highly active antiretroviral therapy: a systematic review. J Antimicrob Chemother 2007; 60: 724-32.
40. Gebo KA, Fleishman JA, Conviser R, Reilly ED, Korthuis PT, Moore RD, et al. Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001. J Acquir Immune Defic Syndr 2005; 38: 96-103.
41. Giordano TP, White AC Jr, Sajja P, Graviss EA, Arduino RC, Adu-Oppong A, et al. Factors associated with the use of highly active antiretroviral therapy in patients newly entering care in an urban clinic. J Acquir Immune Defic Syndr 2003; 32: 399-405.
42. McNaghten AD, Hanson DL, Dworkin MS, Jones JL; Adult/Adolescent Spectrum of HIV Disease Group. Differences in prescription of antiretroviral therapy in a large cohort of HIV-infected patients. J Acquir Immune Defic Syndr 2003; 32: 499-505.
43. Horstmann E, Brown J, Islam F, Buck J, Agins BD. Retaining HIV-infected patients in care: Where are we? Where do we go from here? Clin Infect Dis 2010; 50: 752-61.
44. Wohl AR, Galvan FH, Myers HF, Garland W, George S, Witt M, et al. Do social support, stress, disclosure and stigma influence retention in HIV care for Latino and African American men who have sex with men and women? AIDS Behav 2011; 15: 1098-110.
45. Rubin MS, Colen CG, Link BG. Examination of inequalities in HIV/AIDS mortality in the United States from a fundamental cause perspective. Am J Public Health 2010; 100: 1053-9.
46. An Q, Hernandez A, Prejean J, German EJ, Thompson H, Hall HI. Geographic differences in HIV infection among Hispanics or Latinos-46 states and Puerto Rico, 2010. MMWR Morb Mortal Wkly Rep 2012; 61(40): 805-10.
47. Macartney S, Bishaw A, Fontenot K. Poverty rates for selected detailed race and Hispanic groups by state and place: 2007-2011. American Community Survey Briefs February 2013. Department of Commerce, Census Bureau (US): Washington; 2013.
48. Phillips AN, Neaton J, Lundgren JD. The role of HIV in serious diseases other than AIDS. AIDS 2008; 22: 2409-18.
49. Centers for Disease Control and Prevention. Diagnoses of HIV infection in the United States and dependent areas, 2012. HIV Surveill Rep 2012; 24: 1-83.